ATC Abstracts

American Transplant Congress abstracts

2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions
View by Date

Saturday, June 2, 2018

5:30pm-7:30pm
Sensing T Cell Killing Activity with Granzyme B Activity Probes

Q. Mac,1 D. Mathews,2 J. Kahla,1 C. Stoffers,1 O. Delmas,1 B. Holt,1 A. Adams,2 G. Kwong.1

Poster Session A: Biomarkers, Immune Monitoring and Outcomes  •  Hall 4EF
5:30pm-7:30pm
Serial Monitoring of Resolution of Sub-Clinical Acute Rejection (subAR) in Kidney Transplant Recipients (KTR) Using a Gene Expression Profile (GEP)

L. Zhao,1 B. Armstrong,2 J. Friedewald,1 T. Whisenant,3 S. Kurian,3 R. Heilman,4 E. Poggio,5 C. Marsh,3 P. Baliga,6 N. Bridges,7 J. Odim,7 M. Brown,7 D. Ikle,2 J. Charette,1 S. Brietigam,1 N. Sustento-Reodica,1 M. Kandpal,1 D. Salomon,3 M. Abecassis.1

Poster Session A: Biomarkers, Immune Monitoring and Outcomes  •  Hall 4EF
5:30pm-7:30pm
Serum Treatment with Fetal Bovine Serum Significantly Increases Luminex-Based HLA Antibody Assay Specificity by Reducing Heterophile Antibody Interference

A. Jaramillo,1 J. House,1 L. Nelson,1 S. Stoll,1 R. Ridgley,1 H. Khamash.2

Poster Session A: Kidney Acute Antibody Mediated Rejection  •  Hall 4EF
5:30pm-7:30pm
SGLT2 Inhibition in Kidney Transplant Recipients with Diabetes

M. Guthoff,1 M. Mahling,1 S. Nadalin,2 N. Heyne.1

Poster Session A: Kidney: Cardiovascular and Metabolic  •  Hall 4EF
5:30pm-7:30pm
Significance of Antibody-Mediated Vascular Rejection (AMVR) on Graft Survival: Correlation with Pure Antibody-Mediated Rejection (AMR)

B. Ozdemir,1 F. Ozdemir,2 A. Terzi,2 G. Ozdemir,1 A. Ok Atilgan,1 E. Ayvazoglu Soy,3 A. Akdur,3 G. Moray,3 M. Haberal.3

Poster Session A: Kidney Acute Antibody Mediated Rejection  •  Hall 4EF
5:30pm-7:30pm
Significant Difference between Proteasome and Immunoproteasome Inhibition in Acute Kidney Injury

F. Han, C. Ding, Y. Zhao, P. Tian.

Poster Session A: Innate Immunity; Chemokines, Cytokines, Complement  •  Hall 4EF
5:30pm-7:30pm
Single Center Experience in Use of Check Point Inhibitors and Outcomes in Kidney Transplant Recipients

K. Venkatachalam, R. Delos Santos, T. Alhamad.

Poster Session A: Kidney Acute Antibody Mediated Rejection  •  Hall 4EF
5:30pm-7:30pm
Single-Center Experience with Sofosbuvir-Based HCV Treatment after Kidney Transplantation

V. Garcia, G. Meinerz, C. da Silva, R. Bruno, E. Keitel.

Poster Session A: Kidney Transplant Goes Viral  •  Hall 4EF
5:30pm-7:30pm
Soluble Fibrinogen-Like Protein 2 Regulates Myeloid-Derived Suppressor Cells Differentiation and Enhances Its Immunosuppressive Function of in Allograft Immunity

C. Yang, T. Zhu.

Poster Session A: Innate Immunity; Chemokines, Cytokines, Complement  •  Hall 4EF
5:30pm-7:30pm
Staged Biliary Reconstruction after Liver Transplantation Reduces Post-Transplant Biliary Complications in High-Acuity Patients

T. Pearson, M. Zimmerman, J. Kim, P. Palines, M. Wong, C. Erickson, J. Hong.

Poster Session A: Liver Retransplantation and Other Complications  •  Hall 4EF